In October 2024, Linnea team was thrilled to exhibit at CPHI Milan, the premier global gathering for the pharmaceutical industry
It has been a true pleasure connecting with market leaders, key stakeholders, partners and clients from across Europe, Asia, the Americas, Africa and the Middle East—regions where we supply our high-quality, standardized products.
Showcasing Swiss Excellence: Linnea’s Botanical APIs
At the recent CPHI Milan event, we showcased our innovative solutions and extensive portfolio of botanical-derived APIs.
Linnea proudly represented the Swiss API manufacturing sector at the Integrated Pharma Pavilion as one of the key ambassadors for Swiss players in botanical extract production.
> Explore our product portfolio
Linnea® Butylscopolamine since 1985
A highlight of our product range is Linnea® Butylscopolamine, a key API that we have been producing since 1985. To ensure a reliable supply throughout the year, we are also proud to be vertically integrated with our own GACP plantation and facility in Australia, where we cultivate and process our botanicals according to the highest quality standards.
> Discover Linnea® Butylscopolamine
Unveiling Linnea® Cannabinoids: Innovation & Milestones
With expertise in cannabinoid extraction and formulation, Linnea® Cannabinoids offers a diverse portfolio, including CBD, CBG, THC extracts, and customizable white label B2B solutions for seamless market entry.
> Learn more about our innovative and standardized cannabinoid products
Elevating quality standards in medical cannabinoids: Linnea sets a new milestone with a CEP application for its Cannabidiol (CBD) API
We are especially proud to announce a significant milestone: in early October 2024, Linnea submitted a CEP application for its Cannabidiol (CBD) API—making it one of the first companies globally to take this important step.
This initiative reflects our commitment to providing standardized GMP solutions that meet the highest industry standards.
> Learn more about our commitment to quality
> Info & inquiries at [email protected]